Back to Search
JAIME LLOVET, MD
MD
Family Medicine Physician
NPI: 1013707264Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
PMID 17087938·Gastroenterology·2006
8-other
Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
PMID 16431301·Clin Gastroenterol Hepatol·2006
5-case
Resection and liver transplantation for hepatocellular carcinoma.
PMID 15918147·Semin Liver Dis·2005
6-review
Non-surgical therapies of hepatocellular carcinoma.
PMID 15827440·Eur J Gastroenterol Hepatol·2005
6-review
Molecular profiling to predict hepatocellular carcinoma outcome.
PMID 19351279·Expert Rev Gastroenterol Hepatol·2009
8-other
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.
PMID 19524573·Gastroenterology·2009
8-other
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
PMID 19362088·Gastroenterology·2009
4-observational
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
PMID 19117042·Cancer·2009
4-observational
Pathogenesis of hepatocellular carcinoma and molecular therapies.
PMID 19387255·Curr Opin Gastroenterol·2009
6-review
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.
PMID 19234449·Nat Biotechnol·2009
7-preclinical
Testing molecular therapies in hepatocellular carcinoma: the need for randomized phase II trials.
PMID 19139428·J Clin Oncol·2009
8-other
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.
PMID 19221438·J Clin Invest·2009
7-preclinical
Lin28 promotes transformation and is associated with advanced human malignancies.
PMID 19483683·Nat Genet·2009
7-preclinical
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
PMID 19058754·Lancet Oncol·2009
8-other
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
PMID 19665249·J Hepatol·2009
7-preclinical
Pivotal role of mTOR signaling in hepatocellular carcinoma.
PMID 18929564·Gastroenterology·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 905C S FRONTAGE RD
MERIDIAN, MS 39301 - Phone
- (601) 482-4955
Quick Facts
- NPI
- 1013707264
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile